EIF2AK3 and osteogenesis imperfecta type 4: Interestingly, in osteoblasts with a G589S substitution from a type IV OI patient, BIP was significantly increased compared to control (Days 0, 7, 14), which coordinates with the consistently increased PERK activation in this patient’s osteoblasts.